Jafron Biomedical Co Ltd (300529) — Cash Flow-to-Debt Ratio
Jafron Biomedical Co Ltd (300529) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥35.34 Million could theoretically repay 0% of its total liabilities (CN¥2.11 Billion) in one year. See how financially flexible is Jafron Biomedical Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jafron Biomedical Co Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Jafron Biomedical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see Jafron Biomedical Co Ltd cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Jafron Biomedical Co Ltd (2011–2025)
Year-by-year debt coverage analysis for Jafron Biomedical Co Ltd. Check Jafron Biomedical Co Ltd (300529) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.37x | CN¥721.22 Million | CN¥1.94 Billion | ▼ -27.4% |
| 2024 | 0.51x | CN¥1.05 Billion | CN¥2.05 Billion | ▲ +33.8% |
| 2023 | 0.38x | CN¥916.74 Million | CN¥2.39 Billion | ▼ -20.9% |
| 2022 | 0.48x | CN¥883.80 Million | CN¥1.82 Billion | ▼ -44.6% |
| 2021 | 0.88x | CN¥1.25 Billion | CN¥1.43 Billion | ▼ -65.0% |
| 2020 | 2.50x | CN¥957.49 Million | CN¥383.06 Million | ▲ +38.8% |
| 2019 | 1.80x | CN¥583.50 Million | CN¥324.13 Million | ▲ +54.7% |
| 2018 | 1.16x | CN¥384.08 Million | CN¥330.04 Million | ▲ +19.0% |
| 2017 | 0.98x | CN¥304.10 Million | CN¥310.90 Million | ▼ -36.6% |
| 2016 | 1.54x | CN¥178.64 Million | CN¥115.81 Million | ▼ -6.3% |
| 2015 | 1.65x | CN¥205.18 Million | CN¥124.61 Million | ▲ +3.8% |
| 2014 | 1.59x | CN¥137.35 Million | CN¥86.59 Million | ▼ -2.9% |
| 2013 | 1.63x | CN¥133.33 Million | CN¥81.60 Million | ▼ -31.1% |
| 2012 | 2.37x | CN¥120.25 Million | CN¥50.74 Million | ▼ -5.7% |
| 2011 | 2.51x | CN¥77.06 Million | CN¥30.68 Million | — |